Quality of life: An overview of issues for use in occupational therapy outcome measurement
✍ Scribed by Jacki Liddle; Kryss McKenna
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 121 KB
- Volume
- 47
- Category
- Article
- ISSN
- 0045-0766
No coin nor oath required. For personal study only.
✦ Synopsis
The concept of quality of life (QOL) has been used as an outcome measure to indicate the global health, functioning and wellbeing of a person following illness, injury or disability, and to evaluate the effectiveness of therapeutic interventions. Whilst QOL has been widely used for these purposes by researchers and practitioners in the health and social sciences, it has had limited application by occupational therapists. This has occurred despite the obvious links to occupational therapy philosophy, with both having a multifaceted, holistic, and client‐centred approach to people’s lives, and a concern with the roles and functions that give life meaning and value. This paper reviews QOL literature in order to introduce occupational therapists to the issues involved with using this construct, from its conceptualization to its measurement. A guide to the decision‐making processes involved in selecting an appropriate QOL outcome measure for use in occupational therapy practice is provided.
📜 SIMILAR VOLUMES
## Abstract ## Objective To assess a generic measure of health‐related quality of life (HRQOL) as an outcome measure in granulomatosis with polyangiitis (Wegener's) (GPA). ## Methods Subjects were participants in the Wegener's Granulomatosis Etanercept Trial (WGET) or the Vasculitis Clinical Res
## Abstract ## BACKGROUND. Health‐related quality of life (HRQOL) has not been adequately measured in bladder cancer. A recently developed reliable and disease‐specific quality of life instrument (Bladder Cancer Index, BCI) was used to measure urinary, sexual, and bowel function and bother domains
Assessment of health related quality of life (QOL) has become an important endpoint in many clinical trials of cancer therapy. Most of these studies entail multiple QOL scales that are assessed repeatedly over time. As a result, the problem of multiple comparisons is a primary analytic challenge wit